367 related articles for article (PubMed ID: 15650228)
41. Cloning of genetically tagged chromosome break sequences reveals new fragile sites at 6p21 and 13q22.
Fechter A; Buettel I; Kuehnel E; Schwab M; Savelyeva L
Int J Cancer; 2007 Jun; 120(11):2359-67. PubMed ID: 17290399
[TBL] [Abstract][Full Text] [Related]
42. [Comparison of the common fragile sites and G-banding patterns of chromosomes among rhesus monkeys, white-eyebrow gibbons and human being].
Wang Y; Shi LM
Yi Chuan Xue Bao; 1989; 16(3):188-96. PubMed ID: 2629913
[TBL] [Abstract][Full Text] [Related]
43. Correlation of fragile sites and bleomycin induced chromosome break points.
Murthy SK; Patel JK; Krishnamurthy DS
Indian J Exp Biol; 1989 May; 27(5):442-4. PubMed ID: 2480936
[TBL] [Abstract][Full Text] [Related]
44. Common fragile sites as targets for chromosome rearrangements.
Arlt MF; Durkin SG; Ragland RL; Glover TW
DNA Repair (Amst); 2006 Sep; 5(9-10):1126-35. PubMed ID: 16807141
[TBL] [Abstract][Full Text] [Related]
45. Interstitial telomere DNA sequences are not detectable at breaking sites of classical heritable fragile sites.
Petit P
Hum Genet; 1997 Mar; 99(3):424. PubMed ID: 9050935
[No Abstract] [Full Text] [Related]
46. Common fragile sites: mechanisms of instability revisited.
Debatisse M; Le Tallec B; Letessier A; Dutrillaux B; Brison O
Trends Genet; 2012 Jan; 28(1):22-32. PubMed ID: 22094264
[TBL] [Abstract][Full Text] [Related]
47. Fragile sites are preferential targets for integrations of MLV vectors in gene therapy.
Bester AC; Schwartz M; Schmidt M; Garrigue A; Hacein-Bey-Abina S; Cavazzana-Calvo M; Ben-Porat N; Von Kalle C; Fischer A; Kerem B
Gene Ther; 2006 Jul; 13(13):1057-9. PubMed ID: 16511518
[TBL] [Abstract][Full Text] [Related]
48. Preferential integration of marker DNA into the chromosomal fragile site at 3p14: an approach to cloning fragile sites.
Rassool FV; McKeithan TW; Neilly ME; van Melle E; Espinosa R; Le Beau MM
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6657-61. PubMed ID: 1862089
[TBL] [Abstract][Full Text] [Related]
49. Chromosomal fragile sites FRA3B and FRA16D show correlated expression and association with failure of apoptosis in lymphocytes from patients with thyroid cancer.
Sbrana I; Veroni F; Nieri M; Puliti A; Barale R
Genes Chromosomes Cancer; 2006 May; 45(5):429-36. PubMed ID: 16419058
[TBL] [Abstract][Full Text] [Related]
50. Replication timing of two human common fragile sites: FRA1H and FRA2G.
Pelliccia F; Bosco N; Curatolo A; Rocchi A
Cytogenet Genome Res; 2008; 121(3-4):196-200. PubMed ID: 18758159
[TBL] [Abstract][Full Text] [Related]
51. Fragile site analysis: its significance in environmental mutagenesis.
Ahuja YR
Prog Clin Biol Res; 1990; 340B():371-84. PubMed ID: 2203016
[No Abstract] [Full Text] [Related]
52. Genome-wide retroviral insertional tagging of genes involved in cancer in Cdkn2a-deficient mice.
Lund AH; Turner G; Trubetskoy A; Verhoeven E; Wientjens E; Hulsman D; Russell R; DePinho RA; Lenz J; van Lohuizen M
Nat Genet; 2002 Sep; 32(1):160-5. PubMed ID: 12185367
[TBL] [Abstract][Full Text] [Related]
53. FRA7G extends over a broad region: coincidence of human endogenous retroviral sequences (HERV-H) and small polydispersed circular DNAs (spcDNA) and fragile sites.
Huang H; Qian J; Proffit J; Wilber K; Jenkins R; Smith DI
Oncogene; 1998 May; 16(18):2311-9. PubMed ID: 9620548
[TBL] [Abstract][Full Text] [Related]
54. Chromosomal expression and localization of aphidicolin-induced fragile sites in the standard karyotype of river buffalo (Bubalus bubalis).
Nicodemo D; Coppola G; Pauciullo A; Cosenza G; Ramunno L; Ciotola F; Peretti V; Di Meo GP; Iannuzzi L; Rubes J; Di Berardino D
Cytogenet Genome Res; 2008; 120(1-2):178-82. PubMed ID: 18467845
[TBL] [Abstract][Full Text] [Related]
55. Oncogene-induced replication stress preferentially targets common fragile sites in preneoplastic lesions. A genome-wide study.
Tsantoulis PK; Kotsinas A; Sfikakis PP; Evangelou K; Sideridou M; Levy B; Mo L; Kittas C; Wu XR; Papavassiliou AG; Gorgoulis VG
Oncogene; 2008 May; 27(23):3256-64. PubMed ID: 18084328
[TBL] [Abstract][Full Text] [Related]
56. [Genetic aspects of autosomal fragile sites. Apropos of 40 Cases].
Guichaoua M; Matteï MG; Matteï JF; Giraud F
J Genet Hum; 1982 Oct; 30(3):183-97. PubMed ID: 7153767
[TBL] [Abstract][Full Text] [Related]
57. Instability at chromosomal fragile sites.
Glover TW
Recent Results Cancer Res; 1998; 154():185-99. PubMed ID: 10027000
[TBL] [Abstract][Full Text] [Related]
58. Components of DNA damage checkpoint pathway regulate UV exposure-dependent alterations of gene expression of FHIT and WWOX at chromosome fragile sites.
Ishii H; Mimori K; Inageta T; Murakumo Y; Vecchione A; Mori M; Furukawa Y
Mol Cancer Res; 2005 Mar; 3(3):130-8. PubMed ID: 15798093
[TBL] [Abstract][Full Text] [Related]
59. Chromosomal instability in chronic myeloid leukemia: Philadelphia breakpoints are irrespective to spontaneous breakage and fragile sites.
Fundia AF; Acevedo SH; Larripa IB
Haematologica; 2000 Oct; 85(10):1104-6. PubMed ID: 11025611
[No Abstract] [Full Text] [Related]
60. A survey of homozygous deletions in human cancer genomes.
Cox C; Bignell G; Greenman C; Stabenau A; Warren W; Stephens P; Davies H; Watt S; Teague J; Edkins S; Birney E; Easton DF; Wooster R; Futreal PA; Stratton MR
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4542-7. PubMed ID: 15761058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
